Evidence map›Paper›PMID 42837374›Full record

ArticlePLoS pathogens2026

Sex differences in hepatitis A virus infection in mice.

Ichiro Misumi, Itoe Shiota, Tomoyuki Shiota, Jingyu Zhao, John M Cullen, Stanley M Lemon, Jason K Whitmire

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ichiro MisumiDepartment of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Itoe ShiotaDepartment of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Tomoyuki ShiotaDepartment of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.
Jingyu ZhaoDepartment of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
John M CullenCollege of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, United States of America.
Stanley M LemonLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Jason K WhitmireDepartment of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0003-2578-6073

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT S. SANDLER · 1985 to 2026
$30.5M
Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped HepatovirusR01AI103083 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEMON, STANLEY M. · 2012 to 2021
$4.0M
Regulation of CD8+ T cell responses to chronic virus infectionR01AI143894 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WHITMIRE, JASON KYLE · 2019 to 2023
$2.5M
Obesity associated viral pathogenesisR01AI138337 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WHITMIRE, JASON KYLE · 2018 to 2022
$1.9M
Murine Model of Human Hepatitis AR01AI131685 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEMON, STANLEY M., WHITMIRE, JASON KYLE · 2017 to 2021
$1.9M
Hepatoselective Dihydroquinolizinone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) InfectionR41AI177204 · NIAID · HARLINGENE LIFE SCIENCES LLC · PI DU, YANMING · 2023 to 2024
$600k
Antiviral inhibition of ZCCHC14-TENT4 complex in hepatitis A virus infectionR21AI163606 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, YOU, MISUMI, ICHIRO · 2021 to 2022
$428k
NCI NIH HHS P30 CA016086NIAID NIH HHS R01 AI103083NIAID NIH HHS R01 AI131685NIAID NIH HHS R01 AI138337NIAID NIH HHS R01 AI143894NIAID NIH HHS R21 AI163606NIAID NIH HHS R41 AI177204NIDDK NIH HHS P30 DK034987
6 · The paper itself

Abstract

Epidemiological studies show that more men are hospitalized for severe hepatitis A than women. However, the extent to which social and behavioral differences versus intrinsic biological mechanisms account for this disparity in disease incidence remains unclear. To better define how sex influences infection outcome, we challenged male and female Ifnar1-/- mice with HAV and quantified virus replication and liver injury. Male mice replicated and shed more virus than female mice, and demonstrated both accelerated and more severe liver injury, as evidenced by increased serum alanine aminotransferase (ALT) activity, greater immune cell infiltration in the liver, and higher intrahepatic expression of chemokines and interferon-stimulated genes. Sex differences were apparent in young and older adult mice, indicating that age did not significantly influence these effects. Ovariectomized female mice had higher intrahepatic viral loads, greater serum ALT elevation, and more severe pathology, compared to surgical controls. Conversely, ovariectomized mice given estradiol implants showed reduced viral loads and ALT activity, indicating that estrogen exerts a protective effect. Female Ifnar1-/- mice lacking hepatocellular expression of estrogen receptor were phenotypically similar to those expressing Esr1, indicating that direct ESR1 signaling in hepatocytes is not essential for protection against pathogenesis. Collectively, these findings indicate that sex influences the pathogenesis and outcome of HAV infection and that female sex hormones protect against severe liver injury.

Indexed as

Hepatitis AHepatitis A virusSex CharacteristicsAlanine TransaminaseAnimalsEstrogen Receptor alphaFemaleLiverMaleMiceMice, Inbred C57BLMice, KnockoutOvariectomyReceptor, Interferon alpha-betaSex FactorsViral LoadAlanine TransaminaseEstrogen Receptor alphaIfnar1 protein, mouseReceptor, Interferon alpha-beta

Identifiers

PMID42837374
PMCPMC13641395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.